Skip to content

Total Equity at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$51.93B+5.2%
Danaher logo
DanaherDHR
$52.95B+4.1%
Agilent Technologies logo
Agilent TechnologiesA
$7.12B+16.1%
Illumina logo
IlluminaILMN
$2.68B+13.0%
Revvity logo
RevvityRVTY
$7.18B-5.9%
TEC
Bio-TechneTECH

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$5.45B+24.4%

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Twist Bioscience Corporation's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Twist Bioscience Corporation's total equity?
Twist Bioscience Corporation (TWST) reported total equity of $455.09M in Q1 2026.
How has Twist Bioscience Corporation's total equity changed year-over-year?
Twist Bioscience Corporation's total equity increased by 3.4% year-over-year, from $440.11M to $455.09M.
What is the long-term trend for Twist Bioscience Corporation's total equity?
Over 5 years (2020 to 2025), Twist Bioscience Corporation's total equity has grown at a 7.1% compound annual growth rate (CAGR), from $336.26M to $472.96M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.